Storia della carriera di Mark Hernon
Precedenti posizioni note di Mark Hernon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RUBIUS THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/09/2021 | 01/09/2022 |
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 04/12/2017 | 01/03/2021 |
Formazione di Mark Hernon
| Rensselaer Polytechnic Institute | Graduate Degree |
| The Lally School of Management & Technology | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Borsa valori
- Insiders
- Mark Hernon
- Esperienza
